A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH

Oncogene

Volumn 25, Issue 49, 2006, Pages 6544-6553

  Roylance, R ^a   Gorman, P ^a   Papior, T ^a   Wan, Y L ^a   Ives, M ^a   Watson, J E ^b,h   Collins, C ^b   Wortham, N ^a   Langford, C ^c   Fiegler, H ^c   Carter, N ^c   Gillett, C ^d   Sasieni, P ^e   Pinder, S ^f   Hanby, A ^g   Tomlinson, I ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h AMGEN INC   (United States)

Author keywords

Array CGH; Breast cancer; Chromosome 169

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DUCT; CHROMOSOME 16Q; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME LOSS; CHROMOSOME NUMBER; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE LOSS; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 16; CLUSTER ANALYSIS; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DELETION; HUMANS; LINKAGE (GENETICS); LOSS OF HETEROZYGOSITY; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; TISSUE ARRAY ANALYSIS;

EID: 33750218270     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209659     Document Type: Article

References (34)

1. Barnes DM, Millis RR, Gillett CE, Ryder K, Skilton D, Fentiman IS et al. (2004). Endocr Relat Cancer 11: 85-96.
2. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C et al. (1995). EMBO J 14: 6107-6115.
3. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F et al. (1996). Oncogene 13: 1919-1925.
4. Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R et al. (1999). J Pathol 189: 521-526.
5. Cleton-Jansen AM. (2002). Breast Cancer Res 4: 5-8.
6. Cleton-Jansen AM, Buerger H, Haar N, Philippo K, van de Vijver MJ, Boecker W et al. (2004). Genes Chromosomes Cancer 41: 109-116.
7. Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, McCallum B, Crawford J et al. (2001). Cancer Res 61: 1171-1177.
8. Cleton-Jansen AM, Moerland EW, Pronk JC, van Berkel CG, Apostolou S, Crawford J et al. (1999). Br J Cancer 79: 1049-1052.
9. Cooper LS, Gillett CE, Patel NK, Barnes DM, Fentiman IS. (1999). Cancer 86: 2053-2058.
10. Crawford J, Ianzano L, Savino M, Whitmore S, Cleton-Jansen AM, Settasatian C et al. (1999). Genomics 56: 90-97.
11. Devilee P, Cleton-Jansen AM, Cornelisse CJ. (2001). Trends Genet 17: 569-573.
12. Dorion-Bonnet F, Mautalen S, Hostein I, Longy M. (1995). Genes Chromosomes Cancer 14: 171-181.
13. Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W et al. (2004). Cancer Res 64: 4817-4825.
14. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR. (2001). Int J Cancer 92: 404-408.
15. Elston CW, Ellis IO. (1991). Histopathology 19: 403-410.
16. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE et al. (2003). Genes Chromosomes Cancer 36: 361-374.
17. Frengen E, Rocca-Serra P, Shaposhnikov S, Taine L, Thorsen J, Bepoldin C et al. (2000). Genomics 70: 273-285.
18. Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE et al. (2004). Cancer 100: 2562-2572.
19. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D. (2002). Genome Res 12: 325-332.
20. Kern SE. (2002). Cancer Biol Ther 1: 571-581.
21. Korsching E, Packeisen J, Helms MW, Kersting C, Voss R, van Diest PJ et al. (2004). Br J Cancer 90: 1422-1428.
22. Millis RR, Barnes DM, Lampejo OT, Egan MK, Smith P. (1998). Eur J Cancer 34: 548-553.
23. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N et al. (1997). Int J Cancer 74: 513-517.
24. Pandis N, Idvall I, Bardi G, Jin Y, Gorunova L, Mertens F et al. (1996). Int J Cancer 66: 191-196.
25. Quon KC, Berns A. (2001). Genes Dev 15: 2917-2921.
26. Roylance R, Droufakou S, Gorman P, Gillett C, Hart IR, Hanby A et al. (2003). J Pathol 200: 53-58.
27. Roylance R, Gorman P, Hanby A, Tomlinson I. (2002). J Pathol 196: 32-36.
28. Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A et al. (1999). Cancer Res 59: 1433-1436.
29. Santarosa M, Ashworth A. (2004). Biochim Biophys Acta 1654: 105-122.
30. Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU et al. (2005). Am J Hum Genet 77: 78-88.
31. Tomlinson IP, Lambros MB, Roylance RR. (2002). Genes Chromosomes Cancer 34: 349-353.
32. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S. (1994). Cancer Res 54: 513-517.
33. Watson JE, Doggett NA, Albertson DG, Andaya A, Chinnaiyan A, van Dekken H et al. (2004). Oncogene 23: 3487-3494.
34. Whitmore SA, Crawford J, Apostolou S, Eyre H, Baker E, Lower KM et al. (1998). Genomics 50: 1-8.